PDS Biotechnology Corp 8-K

What Happened PDS Biotechnology Corporation (PDSB) filed a Form 8-K to announce its 2026 Annual Meeting of Stockholders is scheduled for August 10, 2026. The company said it will provide more details in its Definitive Proxy Statement on Schedule 14A to be filed with the SEC. Because the meeting date is more than 30 days from the anniversary of the 2025 annual meeting, the Board set a deadline of June 25, 2026 for stockholders to submit proposals under SEC Rule 14a-8 for inclusion in the company’s proxy materials.

Key Details

• Annual meeting date: August 10, 2026.
• Stockholder proposal deadline (Rule 14a-8): June 25, 2026.
• Proxy details: Definitive Proxy Statement on Schedule 14A to be filed with the SEC.
• Proposal submissions: Send to PDS Biotechnology Corporation, 303A College Road East, Princeton, NJ 08540, Attention: Corporate Secretary; proposals must comply with SEC rules and may be omitted if noncompliant.

Why It Matters This notice sets the official meeting date and the last date for stockholders to submit proposals to appear in the company’s proxy materials. Retail investors who want to propose shareholder initiatives or nominate directors under Rule 14a-8 must meet the June 25, 2026 deadline and follow SEC and company requirements to ensure their proposals are included.